Altimmune, Inc. (ALT) Tops Q1 EPS by 6c
Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.18), $0.06 better than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.18), $0.06 better than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.